Nano-structures mediated co-delivery of therapeutic agents for glioblastoma treatment: A review

被引：64
作者：
Mujokoro, Basil [1 ]
Adabi, Mohsen [2 ]
Sadroddiny, Esmaeil [3 ]
Adabi, Mahdi [4 ]
Khosravani, Masood [4 ]
机构：
[1] Univ Tehran Med Sci, Sch Adv Technol Med, Dept Med Nanotechnol, Int Campus, Tehran, Iran
[2] Islamic Azad Univ, Roudehen Branch, Young Researchers & Elite Club, Roudehen, Iran
[3] Univ Tehran Med Sci, Sch Adv Technol Med, Dept Med Biotechnol, Tehran, Iran
[4] Univ Tehran Med Sci, Sch Adv Technol Med, Dept Med Nanotechnol, Tehran, Iran
来源：
MATERIALS SCIENCE AND ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS | 2016年 / 69卷
关键词：
Glioblastoma; Co-delivery; Drug delivery; Nanoparticle; Chemotherapy; Chemosensitizer; Gene therapy; SOLID LIPID NANOPARTICLES; CONVECTION-ENHANCED DELIVERY; BEVACIZUMAB PLUS IRINOTECAN; GROWTH-FACTOR RECEPTOR; HUMAN SERUM-ALBUMIN; PHASE-II TRIAL; DRUG-DELIVERY; TEMOZOLOMIDE RESISTANCE; RECURRENT GLIOBLASTOMA; IN-VITRO;
D O I：
10.1016/j.msec.2016.07.080
中图分类号：
TB3 [工程材料学]; R318.08 [生物材料学];
学科分类号：
0805 ; 080501 ; 080502 ;
摘要：
Glioblastoma is a malignant brain tumor and leads to death in most patients. Chemotherapy is a common method for brain cancer in clinics. However, the recent advancements in the chemotherapy of brain tumors have not been efficient enough. With the advancement of nanotechnology, the used drugs can enhance chemotherapy efficiency and increase the access to brain cancers. Combination of therapeutic agents has been recently attracted great attention for glioblastoma chemotherapy. One of the early benefits of combination therapies is the high potential to provide synergistic effects and decrease adverse side effects associated with high doses of single anticancer drugs. Therefore, brain tumor treatments with combination drugs can be considered as a crucial approach for avoiding tumor growth. This review investigates current progress in nano-mediated co-delivery of therapeutic agents with focus on glioblastoma chemotherapy prognosis. (C) 2016 Elsevier B.V. All rights reserved.
引用
收藏
页码：1092 / 1102
页数：11
相关论文
共 119 条
[1]  
Adabi M., 2016, ARTIE CELLS NANOMED, P1
[2]   Strategy for effective brain drug delivery [J].
Alam, M. Intakhab ;
Beg, Sarwar ;
Samad, Abdus ;
Baboota, Sanjula ;
Kohli, Kanchan ;
Ali, Javed ;
Ahuja, Alka ;
Akbar, M. .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2010, 40 (05) :385-403
[3]   Local Delivery of Ferrociphenol Lipid Nanocapsules Followed by External Radiotherapy as a Synergistic Treatment Against Intracranial 9L Glioma Xenograft [J].
Allard, Emilie ;
Jarnet, Delphine ;
Vessieres, Anne ;
Vinchon-Petit, Sandrine ;
Jaouen, Gerard ;
Benoit, Jean-Pierre ;
Passirani, Catherine .
PHARMACEUTICAL RESEARCH, 2010, 27 (01) :56-64
[4]   Phase 2 trial of temozolomide and pegylated liposomal doxorubicin in the treatment of patients with glioblastoma multiforme following concurrent radiotherapy and chemotherapy [J].
Ananda, Sumitra ;
Nowak, Anna K. ;
Cher, Lawrence ;
Dowling, Anthony ;
Brown, Chris ;
Simes, John ;
Rosenthal, Mark A. .
JOURNAL OF CLINICAL NEUROSCIENCE, 2011, 18 (11) :1444-1448
[5]  
[Anonymous], INT J MOL MED
[6]  
[Anonymous], 2014, SOJ PHARM PHARM SCI
[7]   Salvage therapy for recurrent glioblastoma multiforme: a multimodal approach combining fluorescence-guided resurgery, interstitial irradiation, and chemotherapy [J].
Archavlis, Eleftherios ;
Tselis, Nikolaos ;
Birn, Gerhard ;
Ulrich, Peter ;
Zamboglou, Nikolaos .
NEUROLOGICAL RESEARCH, 2014, 36 (12) :1047-1055
[8]   Impact of extent of resection for recurrent glioblastoma on overall survival Clinical article [J].
Bloch, Orin ;
Han, Seunggu J. ;
Cha, Soonmee ;
Sun, Matthew Z. ;
Aghi, Manish K. ;
McDermott, Michael W. ;
Berger, Mitchel S. ;
Parsa, Andrew T. .
JOURNAL OF NEUROSURGERY, 2012, 117 (06) :1032-1038
[9]  
BODLEY A, 1989, CANCER RES, V49, P5969
[10]   Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse [J].
Brada, M ;
Hoang-Xuan, K ;
Rampling, R ;
Dietrich, PY ;
Dirix, LY ;
Macdonald, D ;
Heimans, JJ ;
Zonnenberg, BA ;
Bravo-Marques, JM ;
Henriksson, R ;
Stupp, R ;
Yue, N ;
Bruner, J ;
Dugan, M ;
Rao, S ;
Zaknoen, S .
ANNALS OF ONCOLOGY, 2001, 12 (02) :259-266
12345678910